Auf dieser Seite
CRL Charles River Laboratories International, Inc. Common Stock
NYSE · Life Sciences Tools & Services · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$290,19
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$146,2052-Wochen-Tief
$303,3152-Wochen-Hoch
Marktkapitalisierung (MRQ)
$13.85B
P/E (TTM)
-60.5
EPS (TTM)
$-4.80
Umsatz (TTM)
$4.00B
Ihre Abzeichen
52W-Spanne
$146–$303
Analystenbewertung
BUY
Kursziel
$305
P/E
-60.5
ROE
-7.7%
Nettogewinnmarge
-6.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CRL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$290.19
Marktkapitalisierung (MRQ)
$13.85B
P/E (TTM)
-60.5
EPS (TTM)
$-4.80
Umsatz (TTM)
$4.00B
ROE (TTM)
-7.7%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$146–$303
CRL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Charles River Laboratories International, Inc. Common Stock Unternehmensübersicht von Wikipedia
Charles River Laboratories ist ein US-amerikanisches Unternehmen, das Forschungs- und Analytikdienstleistungen für Pharmazieunternehmen und Forschungseinrichtungen anbietet.
Das Unternehmen analysiert Grundstoffe der Pharmakaherstellung hinsichtlich möglicher Verunreinigungen, bietet klinische Labordienstleistungen an und erbringt weitere Dienstleistungen zur Unterstützung pharmazeutischer Forschungsarbeit bei seinen Kunden. Ein wichtiges Geschäftsfeld von Charles River ist die Aufzucht von Modellorganismen wie Mäusen, Ratten und Hamstern für die Durchführung von Tierversuchen. Nach Angaben des Unternehmens war Charles River in die Entwicklung von 85 % aller Arzneimittel eingebunden, die 2019 durch die FDA zugelassen wurden.
Das Unternehmen wurde 1947 durch den Veterinärmediziner Henry Foster in Boston gegründet und nach dem nahen Fluss Charles River benannt. Mit 1000 gekauften Rattenkäfigen begann Henry Foster die Zucht von Versuchstieren für lokale Forschungseinrichtungen. Im Jahr 1966 eröffnete Charles River Laboratories mit einer Zuchteinrichtung in Frankreich seinen ersten Auslandsstandort. Nach der Mondlandung 1969 wurden speziell gezüchtete Mäuse des Unternehmens, die unter der Handelsmarke „Astromice“ vertrieben wurden, zu den ersten Tieren, die gezielt mitgebrachtem Mondstaub zu Versuchszwecken ausgesetzt wurden. Das Unternehmen wurde 1984 an Bausch & Lomb verkauft, Unternehmensgründer Henry Foster verblieb jedoch in der Position der Geschäftsführung. Im Jahr 1997 wurde Charles River durch die Gründerfamilie zurückgekauft und drei Jahre später, im Jahr 2000, an die Börse gebracht.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealthcare
BrancheLife Sciences Tools & Services
Mitarbeiter18.300
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4.02B2016-12-31 → 2025-12-27
EPS$-2.912016-12-31 → 2025-12-27
Freier Cashflow$518M2016-12-31 → 2025-12-27
Nettogewinnmarge-6.0%2016-12-31 → 2025-12-27
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CRL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -60.55-Jahres-Durchschnitt ≈191.6 | ≈191.6 | · | · | |
| P/S (TTM) | 3.55-Jahres-Durchschnitt ≈3.2 | ≈3.2 | 4.9 | Unterbewertet | |
| K/B (MRQ) | 4.95-Jahres-Durchschnitt ≈4.1 | ≈4.1 | 3.6 | Fairer Wert | |
| EV / EBITDA | 32.85-Jahres-Durchschnitt ≈16.9 | ≈16.9 | 25.4 | Unterbewertet | |
| Kurs / FCF (TTM) | 37.45-Jahres-Durchschnitt ≈28.8 | ≈28.8 | · | · | |
| Kurs / Cashflow (TTM) | 23.85-Jahres-Durchschnitt ≈17.3 | ≈17.3 | 26.2 | Unterbewertet | |
| EV / Revenue (EV / Umsatz) | 3.55-Jahres-Durchschnitt ≈3.1 | ≈3.1 | · | · | |
| EV / FCF | 27.15-Jahres-Durchschnitt ≈28.3 | ≈28.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 5.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CRL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 2.3%5-Jahres-Durchschnitt ≈10.8% | ≈10.8% | 12.1% | Im Einklang | |
| EBITDA-Marge (TTM) | 9.7%5-Jahres-Durchschnitt ≈19.2% | ≈19.2% | 14.8% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | -2.5%5-Jahres-Durchschnitt ≈8.6% | ≈8.6% | 12.4% | Schwach | |
| Nettogewinnmarge (TTM) | -6.0%5-Jahres-Durchschnitt ≈6.3% | ≈6.3% | 10.8% | Schwach | |
| ROA (TTM) | -3.2%5-Jahres-Durchschnitt ≈3.4% | ≈3.4% | 2.0% | Schwach | |
| ROE (TTM) | -7.7%5-Jahres-Durchschnitt ≈9.0% | ≈9.0% | 3.3% | Schwach | |
| ROIC | 1.1%5-Jahres-Durchschnitt ≈10.7% | ≈10.7% | 3.0% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CRL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.1 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.35-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 1.8 | Geringe Liquidität | |
| Quick Ratio | 0.85-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 1.2 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CRL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -0.85%5-Jahres-Durchschnitt ≈6.9% | ≈6.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 0.33%5-Jahres-Durchschnitt ≈5.7% | ≈5.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 6.6% | · | · | · | |
| EPS YoY (EPS VjV) | -97.8%5-Jahres-Durchschnitt ≈-17.6% | ≈-17.6% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -95.3%5-Jahres-Durchschnitt ≈-16.5% | ≈-16.5% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -70.3% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -61.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CRL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.5 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 5.65-Jahres-Durchschnitt ≈5.5 | ≈5.5 | 5.6 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$219.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.9%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $3.02 | $2.76 | 9.2% |
| 31. März 2026 | $2.06 | $1.96 | 5.0% | |
| 31. Dezember 2025 | $2.39 | $2.37 | 0.98% | |
| 30. September 2025 | $2.43 | $2.36 | 2.9% | |
| 30. Juni 2025 | $3.12 | $2.52 | 23.7% | |
| 31. März 2025 | $2.34 | $2.10 | 11.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $290M | $277M | $264M | $266M | |
| SG&A Expense | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | |
| Operating Income | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | |
| Interest Expense | · | · | $137M | $59M | $74M | $86M | $61M | $64M | $30M | $28M | $15M | $12M | |
| Interest Income | $5M | $9M | $5M | $780.0K | $652.0K | $834.0K | $2M | $812.0K | $690.0K | $1M | $1M | $1M | |
| Other Non-op | $-23M | $-17M | $96M | $31M | $-36M | $100M | $12M | $13M | $38M | $12M | $3M | $11M | |
| Pretax Income | $-100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | |
| Income Tax | $43M | $68M | $101M | $130M | $82M | $82M | $50M | $54M | $171M | $67M | $43M | $48M | |
| Net Income | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | |
| Shares (Basic) | 49,564,000 | 51,380,000 | 51,227,000 | 50,812,000 | 50,293,000 | 49,550,000 | 48,730,000 | 47,947,000 | 47,481,000 | 47,014,000 | 46,496,000 | 46,627,000 | |
| Shares (Diluted) | 49,564,000 | 51,628,000 | 51,451,000 | 51,301,000 | 51,425,000 | 50,611,000 | 49,693,000 | 49,018,000 | 48,564,000 | 47,958,000 | 47,634,000 | 47,558,000 | |
| EBITDA | $428M | $589M | $931M | $955M | $855M | $668M | $549M | $493M | $419M | $364M | $301M | $274M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $195M | $277M | $234M | $241M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | |
| Short-term Investments | · | · | · | · | $1M | $1M | $941.0K | $885.0K | $28M | $4M | $21M | · | |
| Receivables | $709M | $721M | $780M | $752M | $643M | $618M | $514M | $472M | $430M | $364M | $270M | $258M | |
| Inventory | $299M | $279M | $380M | $256M | $199M | $186M | $161M | $128M | $115M | $96M | $94M | $89M | |
| Prepaid Expense | $129M | $106M | $83M | $108M | $97M | $73M | $56M | $49M | $81M | $45M | $47M | $45M | |
| Other Current Assets | · | · | · | · | · | $0 | $300.0K | $300.0K | $0 | $45M | $47M | $73M | |
| Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $898M | $827M | $657M | $559M | $579M | |
| PP&E (Net) | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B | $1.04B | $933M | $782M | $756M | $678M | $677M | |
| PP&E (Gross) | $3.19B | $3.06B | $2.98B | $2.63B | $2.39B | $2.21B | $2.02B | $1.81B | $1.58B | $1.46B | $1.32B | $1.33B | |
| Accum. Depreciation | $1.54B | $1.45B | $1.34B | $1.16B | $1.10B | $1.09B | $978M | $874M | $801M | $706M | $645M | $655M | |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $805M | $788M | $439M | $321M | |
| Intangibles | $340M | $723M | $864M | $955M | $1.06B | $788M | $689M | $611M | $370M | $394M | $281M | $281M | |
| Other Non-current Assets | $293M | $278M | $309M | $148M | $152M | $353M | $213M | $144M | $124M | $88M | $72M | $73M | |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Accounts Payable | $149M | $140M | $169M | $206M | $198M | $122M | $111M | $66M | $78M | $68M | $37M | $34M | |
| Accrued Liabilities | $270M | $232M | $228M | $220M | $229M | $150M | $139M | $107M | $90M | $84M | $89M | $67M | |
| Current Liabilities | $1.12B | $994M | $1.06B | $1.09B | $1.03B | $840M | $710M | $558M | $464M | $430M | $312M | $295M | |
| Capital Leases | $434M | $484M | $419M | $390M | $253M | $156M | $116M | · | · | · | · | · | |
| Deferred Tax | $95M | $107M | $191M | $216M | $240M | $217M | $167M | $144M | $90M | $56M | $48M | $23M | |
| Other Non-current Liabilities | $138M | $195M | $223M | $175M | $243M | $205M | $183M | $179M | $195M | $159M | $89M | $100M | |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B | $1.17B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.61B | $1.09B | $1.18B | $814M | $717M | |
| Total Debt | $166.0K | $155.0K | $3M | $1M | $101.0K | $47M | $36M | $1.65B | $1.12B | $1.21B | $836M | $754M | |
| Common Stock | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K | $498.0K | $489.0K | $482.0K | $875.0K | $863.0K | $855.0K | $845.0K | |
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $981M | $625M | $280M | $42M | $289M | $165M | $11M | $-139M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $55.0K | $1.66B | $1.55B | $1.54B | $1.42B | |
| AOCI | $-172M | $-317M | $-196M | $-262M | $-165M | $-139M | $-178M | $-173M | $-145M | $-254M | $-136M | $-74M | |
| Stockholders' Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $837M | $733M | $672M | |
| Liabilities + Equity | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Shares Outstanding | 49,217,000 | 51,141,000 | 51,338,000 | 50,944,000 | 50,480,000 | 49,767,000 | 48,936,000 | 48,209,000 | 47,402,000 | 47,363,000 | 46,698,000 | 47,327,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403M | $362M | $314M | $304M | $266M | $235M | $198M | $162M | $131M | $127M | $95M | $96M | |
| Stock-based Comp | $71M | $70M | $72M | $74M | $71M | $56M | $57M | $47M | $44M | $44M | $40M | $31M | |
| Deferred Tax | $-75M | $-67M | $-51M | $-33M | $-20M | $2M | $-21M | $-10M | $28M | $3M | $4M | $9M | |
| Amort. of Intangibles | $179M | $138M | $137M | $147M | $125M | $112M | $90M | $65M | $41M | $42M | $24M | $26M | |
| Restructuring | $100M | $107M | $30M | $8M | $7M | $13M | $14M | $10M | $5M | $18M | $8M | $8M | |
| Other Non-cash | $483M | $348M | $-126M | $-211M | $53M | $-111M | $-5M | $16M | $-8M | $-28M | $-395.0K | · | |
| Operating Cash Flow | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $318M | $317M | $307M | $252M | |
| CapEx | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | |
| Investing Cash Flow | $-209M | $-245M | $-563M | $-608M | $-1.44B | $-602M | $-682M | $-955M | $-73M | $-693M | · | · | |
| Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | $237M | $1.04B | · | · | |
| Net Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | · | · | · | · | |
| Stock Repurchased | $361M | $119M | $24M | $39M | $41M | $24M | $18M | $14M | $107M | $12M | $117M | $122M | |
| Net Stock Activity | $-361M | $-119M | $-24M | $-39M | $-41M | $-24M | $-18M | $-14M | $-107M | $-12M | $-117M | $-122M | |
| Financing Cash Flow | $-537M | $-551M | $-86M | $-42M | $673M | $47M | $232M | $558M | $-208M | $381M | · | · | |
| Net Change in Cash | $10M | $-79M | $43M | $-5M | $13M | $-7M | $43M | $31M | $46M | $-69.0K | $-43M | $4M | |
| Taxes Paid | $120M | $126M | $90M | $76M | $75M | $60M | $54M | $68M | · | · | · | · | |
| Free Cash Flow | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $236M | $245M | $225M | $195M | |
| Levered FCF | · | · | $252M | $248M | $471M | $309M | $290M | $250M | $223M | $226M | $213M | $186M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | |
| Net Margin | -3.6% | 0.55% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | · | |
| Pretax Margin | -2.5% | 2.3% | 14.1% | 15.7% | 13.6% | 15.3% | 11.6% | 12.4% | 16.0% | 13.3% | 14.3% | 13.7% | |
| EBITDA Margin | 10.7% | 14.5% | 22.6% | 24.0% | 24.2% | 22.8% | 20.9% | 21.8% | 22.5% | 21.6% | 22.1% | 21.1% | |
| ROA | -2.0% | 0.28% | 6.0% | 6.7% | 6.2% | 7.1% | 5.9% | 6.7% | 4.4% | 6.5% | 7.6% | · | |
| ROE | -4.4% | 0.63% | 14.4% | 17.6% | 16.8% | 19.4% | 17.1% | 19.2% | 13.1% | 19.7% | 21.2% | · | |
| ROIC | 1.1% | 1.8% | 14.2% | 17.3% | 19.3% | 16.4% | 17.6% | 9.0% | 5.6% | 8.1% | 10.2% | 9.1% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 | 1.4 | 1.4 | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.1 | 1.2 | 1.4 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 | 1.4 | 1.1 | 1.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 1.2 | 1.0 | 1.4 | 1.1 | 1.1 | |
| Interest Coverage | · | · | 4.5 | 11.0 | 8.0 | 5.0 | 5.8 | 5.2 | 9.7 | 8.6 | 13.7 | 14.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.7 | 2.9 | 2.9 | 3.0 | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.7 | 5.6 | 5.2 | 5.3 | 5.0 | 4.7 | 5.3 | 5.2 | 5.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.30 | $67.69 | $70.06 | $58.42 | $50.21 | $42.49 | $33.40 | $27.33 | $22.05 | $17.67 | $15.70 | $14.20 | |
| Revenue / Share | $81.01 | $78.45 | $80.26 | $77.50 | $68.84 | $57.77 | $52.75 | $46.23 | $38.25 | $35.06 | · | · | |
| Cash Flow / Share | $14.88 | $14.23 | $13.29 | $12.08 | $14.79 | $10.80 | $9.68 | $9.00 | $6.55 | $6.26 | · | · | |
| Cash / Share | $4.34 | $3.81 | $5.39 | $4.59 | $4.78 | $4.59 | $4.86 | $4.05 | $3.46 | $2.48 | $2.53 | $3.38 | |
| EPS (TTM) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.85% | -1.9% | 3.9% | 12.3% | 21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.33% | 4.6% | 12.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.8% | -2.7% | 24.7% | 5.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -70.3% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -95.3% | -2.4% | 24.4% | 7.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -61.6% | 9.2% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Net Income TTM | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| Market Cap | $10.02B | $9.52B | $12.14B | $11.10B | $18.64B | $12.53B | $7.43B | $5.39B | $5.19B | $3.61B | $3.74B | $3.04B | |
| Enterprise Value | $9.81B | $9.33B | $11.86B | $10.87B | $18.40B | $12.34B | $7.23B | $6.84B | $6.12B | $4.70B | $4.46B | $3.64B | |
| P/E | -70.0 | 930.8 | 25.6 | 23.0 | 48.6 | 35.0 | 30.0 | 24.2 | 43.1 | 23.6 | 25.6 | 24.2 | |
| P/S | 2.5 | 2.4 | 2.9 | 2.8 | 5.3 | 4.3 | 2.8 | 2.4 | 2.8 | 2.1 | 2.7 | 2.3 | |
| P/B | 3.2 | 2.8 | 3.4 | 3.7 | 7.4 | 5.9 | 4.5 | 4.1 | 5.0 | 4.3 | 5.1 | 4.5 | |
| P / Tangible Book | 166.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 13.6 | 13.0 | 17.7 | 17.9 | 24.5 | 22.9 | 15.5 | 12.2 | 16.3 | 12.0 | 13.0 | 12.1 | |
| P / FCF | 19.3 | 19.0 | 33.2 | 37.6 | 35.0 | 33.0 | 21.8 | 17.9 | 22.0 | 14.7 | 16.6 | 15.6 | |
| EV / EBITDA | 22.9 | 15.8 | 12.7 | 11.4 | 21.5 | 18.5 | 13.2 | 13.9 | 14.6 | 12.9 | 14.8 | 13.3 | |
| EV / FCF | 18.9 | 18.6 | 32.5 | 36.9 | 34.6 | 32.5 | 21.2 | 22.7 | 26.0 | 19.2 | 19.8 | 18.6 | |
| EV / Revenue | 2.4 | 2.3 | 2.9 | 2.7 | 5.2 | 4.2 | 2.8 | 3.0 | 3.3 | 2.8 | 3.3 | 2.8 | |
| Earnings Yield | -1.4% | 0.11% | 3.9% | 4.3% | 2.1% | 2.9% | 3.3% | 4.1% | 2.3% | 4.2% | 3.9% | 4.1% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $996M | $994M | $1.00B | $1.03B | $984M | $1.00B | $1.01B | $1.03B | $1.01B | $1.01B | $1.03B | $1.03B | $1.10B | $989M | |
| Cost of Revenue | · | · | · | · | · | · | · | $661M | $672M | $667M | · | $665M | $652M | · | · | |
| SG&A Expense | $229M | $159M | $196M | $178M | $192M | $178M | $196M | $199M | $170M | $186M | $197M | $176M | $175M | $200M | $184M | |
| Operating Income | $120M | $120M | $-283M | $134M | $100M | $75M | $-168M | $117M | $152M | $126M | $133M | $152M | $168M | $164M | $151M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $34M | $34M | · | $11M | |
| Interest Income | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $1M | $806.0K | $343.0K | $122.0K | |
| Other Non-op | $-37M | $-124M | $12M | $-23M | $154.0K | $-12M | $-23M | $3M | $-2M | $6M | $108M | $-6M | $-3M | $116M | $-17M | |
| Income Tax | $54M | $-15M | $-18M | $32M | $19M | $10M | $-3M | $21M | $25M | $25M | $20M | $25M | $27M | $56M | $25M | |
| Net Income | $-1M | $-15M | $-277M | $54M | $52M | $25M | $-214M | $70M | $94M | $73M | $187M | $87M | $103M | $187M | $96M | |
| EPS (Basic) | $-0.03 | $-0.30 | $-5.58 | $1.11 | $1.06 | $0.50 | $-4.20 | $1.34 | $1.75 | $1.31 | $3.65 | $1.70 | $2.02 | $3.68 | $1.90 | |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.57 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 | $1.74 | $1.30 | $3.64 | $1.69 | $2.01 | $3.66 | $1.88 | |
| Shares (Basic) | 48,021,000 | 48,951,000 | · | 49,213,000 | 49,149,000 | 50,677,000 | · | 51,394,000 | 51,551,000 | 51,437,000 | · | 51,283,000 | 51,097,000 | · | 50,870,000 | |
| Shares (Diluted) | 48,021,000 | 48,951,000 | · | 49,426,000 | 49,316,000 | 50,853,000 | · | 51,583,000 | 51,846,000 | 51,842,000 | · | 51,607,000 | 51,428,000 | · | 51,283,000 | |
| EBITDA | $187M | $187M | · | $219M | $220M | $195M | · | $206M | $238M | $211M | · | $230M | $245M | · | $226M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192M | $192M | $214M | $207M | $183M | $229M | $195M | $210M | $179M | $327M | · | $157M | $202M | · | $194M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Receivables | $712M | $700M | $709M | $734M | $768M | $757M | $721M | $754M | $762M | $787M | · | $799M | $788M | · | $771M | |
| Inventory | $346M | $360M | $299M | $303M | $280M | $290M | $279M | $336M | $349M | $361M | · | $293M | $263M | · | $262M | |
| Prepaid Expense | $179M | $135M | $129M | $166M | $130M | $100M | $106M | $102M | $111M | $99M | · | $93M | $92M | · | $97M | |
| Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B | $1.50B | $1.67B | · | $1.44B | $1.45B | · | $1.42B | |
| PP&E (Net) | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $2.96B | $2.94B | $3.19B | $3.09B | $3.10B | $3.05B | $3.06B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $1.46B | $1.43B | $1.54B | $1.50B | $1.50B | $1.46B | $1.45B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B | $3.08B | $3.07B | · | $2.88B | $2.90B | · | $2.78B | |
| Intangibles | $253M | $249M | $340M | $571M | $602M | $656M | $723M | $778M | $800M | $828M | · | $886M | $958M | · | $968M | |
| Other Non-current Assets | $588M | $826M | $293M | $291M | $296M | $294M | $278M | $307M | $301M | $303M | · | $155M | $154M | · | $430M | |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Accounts Payable | $141M | $134M | $149M | $170M | $146M | $149M | $140M | $136M | $133M | $130M | · | $136M | $120M | · | $182M | |
| Accrued Liabilities | $380M | $372M | $270M | $229M | $232M | $242M | $232M | $208M | $192M | $191M | · | $198M | $221M | · | $197M | |
| Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994M | $1.01B | $948M | $955M | · | $994M | $981M | · | $1.01B | |
| Capital Leases | $408M | $393M | $434M | $443M | $454M | $475M | $484M | $433M | $429M | $418M | · | $390M | $418M | · | $369M | |
| Deferred Tax | $79M | $81M | $95M | $123M | $109M | $107M | $107M | $168M | $165M | $180M | · | $185M | $212M | · | $196M | |
| Other Non-current Liabilities | $403M | $511M | $138M | $189M | $185M | $196M | $195M | $237M | $225M | $235M | · | $173M | $187M | · | $195M | |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B | $4.18B | $4.45B | · | $4.26B | $4.54B | · | $4.71B | |
| Total Debt | $5M | $7M | · | $54.0K | $98.0K | $121.0K | · | $157.0K | $435.0K | $459.0K | · | $797.0K | · | · | $0 | |
| Common Stock | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K | $517.0K | $515.0K | · | $514.0K | $512.0K | · | $510.0K | |
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B | $2.05B | $1.96B | · | $1.72B | $1.54B | · | $1.28B | |
| Treasury Stock | $323M | $210M | $0 | $363M | $363M | $357M | $0 | $120M | $18M | $9M | · | $24M | $19M | · | $38M | |
| AOCI | $-196M | $-191M | $-172M | $-192M | $-166M | $-265M | $-317M | $-193M | $-270M | $-250M | · | $-268M | $-239M | · | $-396M | |
| Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B | $3.72B | $3.64B | · | $3.31B | $3.11B | · | $2.63B | |
| Liabilities + Equity | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Shares Outstanding | 47,728,000 | 48,167,000 | 49,217,000 | 49,215,000 | 49,209,000 | 49,115,000 | 51,141,000 | 51,134,000 | 51,613,000 | 51,510,000 | · | 51,296,000 | 51,182,000 | 50,944,000 | 50,877,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $78M | $85M | $120M | $120M | $102M | $88M | $86M | $85M | $81M | $79M | $77M | $78M | $75M | |
| Stock-based Comp | $20M | $22M | $18M | $23M | $17M | $13M | $17M | $19M | $17M | $17M | $20M | $23M | $13M | $22M | $22M | |
| Amort. of Intangibles | $15M | $15M | $21M | $27M | $65M | $65M | $41M | $32M | $32M | $33M | $34M | $34M | $35M | $35M | $36M | |
| Restructuring | $23M | $32M | $26M | $17M | $32M | $24M | $41M | $31M | $18M | $17M | $8M | $15M | $3M | $4M | $1M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-45M | · | · | $-84M | · | · | |
| Operating Cash Flow | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M | $130M | $221M | $205M | $109M | $235M | $133M | |
| CapEx | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M | $79M | $78M | $66M | $107M | $89M | $72M | |
| Investing Cash Flow | $28M | $-408M | $-93M | $-34M | $-37M | $-45M | $-76M | $-21M | $-62M | $-86M | $-238M | $-80M | $-169M | $44M | $-92M | |
| Debt Issued | $353M | $912M | $157M | $107M | $547M | $416M | $105M | $236M | $440M | $301M | $443M | $51M | $192M | $154M | $618M | |
| Net Debt Issued | · | $912M | · | · | · | $416M | · | · | · | $301M | · | · | $192M | · | · | |
| Stock Repurchased | $116M | $208M | $96.0K | $93.0K | $7M | $353M | $124.0K | $101M | $9M | $9M | $139.0K | $38.0K | $19M | $159.0K | $24.0K | |
| Net Stock Activity | · | $-208M | · | · | · | $-353M | · | · | · | $-9M | · | · | $-19M | · | · | |
| Financing Cash Flow | $-165M | $348M | $-52M | $-153M | $-227M | $-105M | $-76M | $-208M | $-286M | $18M | $124M | $-163M | $25M | $-249M | $-52M | |
| Net Change in Cash | $42M | $-18M | $7M | $24M | $-47M | $26M | $-6M | $31M | $-158M | $54M | $119M | $-43M | $-32M | $45M | $-11M | |
| Taxes Paid | $16M | $2M | $27M | $19M | $57M | $17M | $31M | $23M | $53M | $19M | $15M | $14M | $14M | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $112M | · | · | · | $51M | · | · | $3M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 12.0% | · | 13.3% | 9.7% | 7.6% | · | 11.6% | 14.8% | 12.4% | · | 14.8% | 16.3% | · | 15.3% | |
| Net Margin | -0.15% | -1.5% | · | 5.4% | 5.1% | 2.6% | · | 6.9% | 9.2% | 7.2% | · | 8.5% | 10.0% | · | 9.8% | |
| EBITDA Margin | 18.6% | 18.8% | · | 21.8% | 21.3% | 19.8% | · | 20.4% | 23.2% | 20.9% | · | 22.4% | 23.8% | · | 22.8% | |
| ROA | -0.02% | -0.19% | · | 0.70% | 0.67% | 0.32% | · | 0.89% | 1.2% | 0.92% | · | 1.2% | · | · | 1.3% | |
| ROE | -0.05% | -0.48% | · | 1.5% | 1.5% | 0.75% | · | 2.0% | 2.7% | 2.2% | · | 2.9% | · | · | 3.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 1.5 | · | · | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | · | · | 1.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.6 | · | 4.5 | 4.9 | · | 13.3 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.1 | 2.1 | 2.1 | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.50 | $61.05 | · | $69.20 | $68.14 | $65.04 | · | $73.97 | $72.13 | $70.67 | · | $64.45 | · | · | $51.63 | |
| Revenue / Share | $20.91 | $20.34 | · | $20.33 | $20.93 | $19.35 | · | $19.58 | $19.79 | $19.51 | · | $19.89 | $20.02 | · | $19.29 | |
| Cash Flow / Share | · | $0.84 | · | · | · | $3.38 | · | · | · | $2.51 | · | · | $2.13 | · | · | |
| Cash / Share | $4.02 | $3.98 | · | $4.21 | $3.72 | $4.67 | · | $4.11 | $3.47 | $6.35 | · | $3.06 | · | · | $3.81 | |
| EPS (TTM) | $-4.80 | $-3.71 | · | $-1.51 | $-1.28 | $-0.60 | · | $8.01 | $8.37 | $8.52 | · | $9.25 | $9.68 | · | $8.49 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.00B | $4.03B | · | $4.02B | $4.03B | $4.02B | · | $4.06B | $4.08B | $4.11B | · | $4.22B | $4.09B | · | $3.78B | |
| Net Income TTM | $-238M | $-185M | · | $-82M | $-67M | $-25M | · | $424M | $442M | $444M | · | $475M | $496M | · | $436M | |
| Market Cap | $10.30B | $7.67B | · | $7.31B | $7.38B | $7.64B | · | $10.14B | $10.66B | $13.96B | · | $10.05B | · | · | $9.54B | |
| Enterprise Value | $10.11B | $7.48B | · | $7.10B | $7.20B | $7.41B | · | $9.93B | $10.48B | $13.63B | · | $9.90B | · | · | $9.35B | |
| P/E | -44.9 | -42.9 | · | -98.4 | -117.2 | -259.2 | · | 24.8 | 24.7 | 31.8 | · | 21.2 | 20.8 | · | 22.1 | |
| P/S | 2.6 | 1.9 | · | 1.8 | 1.8 | 1.9 | · | 2.5 | 2.6 | 3.4 | · | 2.4 | 2.5 | · | 2.5 | |
| P/B | 3.6 | 2.6 | · | 2.1 | 2.2 | 2.4 | · | 2.7 | 2.9 | 3.8 | · | 3.0 | · | · | 3.6 | |
| P / Cash Flow | · | 186.6 | · | · | · | 44.5 | · | · | · | 107.5 | · | · | · | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.4 | 2.6 | 3.3 | · | 2.3 | 2.5 | · | 2.5 | |
| Earnings Yield | -2.2% | -2.3% | · | -1.0% | -0.85% | -0.39% | · | 4.0% | 4.0% | 3.1% | · | 4.7% | 4.8% | · | 4.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Umsatz | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| Betriebsgewinnmarge % | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% |
| Nettoergebnis | $-144M | $22M | $475M | $486M | $391M |
| Verwässerte EPS | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
| Kennzahl | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Liquiditätsgrad | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
| Kennzahl | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Freier Cashflow | $518M | $502M | $365M | $295M | $532M |
Institutionelle Eigentümer (13F) 607 Einreicher · $13.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
607
Gehaltener Wert
$13.6B
Neue Positionen
74
Geschlossene Positionen
62
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 74 (-17 vs. Vorquartal) | 62 (-19 vs. Vorquartal) | 193 (0 vs. Vorquartal) | 204 (+13 vs. Vorquartal) | +2.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.174.373.670 | 5.887.175 | 8,65% | Aktien |
| FMR LLC | $961.533.236 | 4.239.752 | 7,09% | Aktien |
| BlackRock, Inc. | $861.475.349 | 3.798.560 | 6,35% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $714.227.026 | 3.149.288 | 5,26% | Aktien |
| Invesco Ltd. | $676.919.391 | 2.984.785 | 4,99% | Aktien |
| HARRIS ASSOCIATES L P | $508.269.048 | 2.241.144 | 3,75% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $501.427.927 | 2.210.979 | 3,70% | Aktien |
| Allspring Global Investments Holdings, LLC | $436.473.035 | 1.905.247 | 3,22% | Aktien |
| STATE STREET CORP | $422.800.968 | 1.864.284 | 3,12% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $373.848.597 | 1.648.450 | 2,76% | Aktien |
| ARIEL INVESTMENTS, LLC | $341.587.697 | 1.506.185 | 2,52% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $295.598.099 | 1.305.738 | 2,18% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $292.210.525 | 1.288.463 | 2,15% | Aktien |
| CITADEL ADVISORS LLC | $270.696.771 | 1.193.601 | 1,99% | Aktien |
| BANK OF AMERICA CORP /DE/ | $265.930.779 | 1.172.586 | 1,96% | Aktien |
| EARNEST PARTNERS LLC | $254.007.295 | 1.120.011 | 1,87% | Aktien |
| AMERIPRISE FINANCIAL INC | $199.834.979 | 881.189 | 1,47% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $195.633.630 | 862.704 | 1,44% | Aktien |
| SEI INVESTMENTS CO | $184.499.540 | 813.530 | 1,36% | Aktien |
| MORGAN STANLEY | $181.542.851 | 800.487 | 1,34% | Aktien |
| Clearbridge Investments, LLC | $177.185.527 | 781.276 | 1,31% | Aktien |
| COOKE & BIELER LP | $171.369.328 | 755.630 | 1,26% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $157.642.604 | 682.173 | 1,16% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $150.762.735 | 664.768 | 1,11% | Aktien |
| UBS Group AG | $146.675.752 | 646.747 | 1,08% | Aktien |
| GOLDMAN SACHS GROUP INC | $145.100.822 | 639.803 | 1,07% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $110.324.717 | 486.462 | 0,81% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $106.061.291 | 467.663 | 0,78% | Aktien |
| BANK OF MONTREAL /CAN/ | $104.270.783 | 459.768 | 0,77% | Aktien |
| NORTHERN TRUST CORP | $101.169.205 | 446.092 | 0,75% | Aktien |
| Gotham Asset Management, LLC | $98.233.181 | 433.146 | 0,72% | Aktien |
| Amundi | $93.528.650 | 412.402 | 0,69% | Aktien |
| NORGES BANK | $83.921.372 | 370.040 | 0,62% | Aktien |
| MARSHALL WACE, LLP | $77.787.835 | 342.995 | 0,57% | Aktien |
| Iron Triangle Partners LP | $75.748.141 | 379.728 | 0,56% | Aktien |
| CITIGROUP INC | $71.714.853 | 316.217 | 0,53% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $69.108.583 | 304.725 | 0,51% | Aktien |
| Bank of New York Mellon Corp | $69.054.385 | 304.486 | 0,51% | Aktien |
| Boston Trust Walden Corp | $65.523.486 | 288.917 | 0,48% | Aktien |
| JPMORGAN CHASE & CO | $65.085.033 | 286.317 | 0,48% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $64.615.913 | 374.585 | 0,48% | Aktien |
| SNYDER CAPITAL MANAGEMENT L P | $63.899.443 | 281.756 | 0,47% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63.174.169 | 278.558 | 0,47% | Aktien |
| DEUTSCHE BANK AG\ | $62.723.084 | 276.569 | 0,46% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $61.384.115 | 270.665 | 0,45% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $60.523.448 | 266.870 | 0,45% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $58.234.910 | 256.779 | 0,43% | Aktien |
| Meridiem Capital Partners LP | $56.012.367 | 246.979 | 0,41% | Aktien |
| Alyeska Investment Group, L.P. | $53.295.650 | 235.000 | 0,39% | Aktien |
| LOOMIS SAYLES & CO L P | $50.725.593 | 223.668 | 0,37% | Aktien |
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| JANA PARTNERS LLC ×4 Einreichungen | 4. August 2011 | · | Erste Einreichung | · | SEC |
| Relational Investors, LLC, Relational Investors Mid-Cap Fund I, L.P., Relational Investors Mid-Cap Fund II, L.P., Ralph V. Whitworth, David H. Batchelder, California State Teachers’ Retirement System ×3 Einreichungen | 9. Februar 2011 | · | Erste Einreichung | · | SEC |
| Neuberger Berman Group LLC, Neuberger Berman LLC, Neuberger Berman Management ×3 Einreichungen | 7. Dezember 2010 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 16. Juni 2010 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 7. Juni 2010 | · | Erste Einreichung | Passive Anlage | SEC |
| Charles River Laboratories International, Inc. IRS No. 061397316 | 5. Mai 2010 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 57 Insider · 23 Führungskräfte · 29 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Birgit Girshick | Chief Executive Officer | 19. August 2026 G | 35.485 | 0 | 1 | $-1.819.350 |
| Glenn Coleman | EVP & Chief Financial Officer | 30. September 2026 P | 27.762 | 1 | 0 | $2.974 |
| Flavia Pease | Corporate Executive VP & CFO | 31. Mai 2025 F | 17.297 | 0 | 0 | $0 |
| David Ross Smith | Corporate Executive VP & CFO | 3. März 2022 M | 25.819 | 0 | 0 | $0 |
| Davide Molho | President & COO | 24. Juli 2018 M | 17.155 | 0 | 0 | $0 |
| Shannon M Parisotto | CEVP, Disc & Safety Assessment | 19. August 2026 M | 4.807 | 0 | 3 | $-2.965.466 |
| Mark Mintz | EVP, Chief Information Officer | 31. Mai 2026 F | 9.546 | 0 | 0 | $0 |
| William D Barbo | Corporate Executive VP & CCO | 7. November 2024 G | 23.337 | 0 | 0 | $0 |
| John W Kuo | CEVP General Counsel & CCO | 1. Juni 2020 A | 3.171 | 0 | 0 | $0 |
| David P Johst | Corporate Executive VP | 29. Mai 2020 A | 224.478 | 0 | 0 | $0 |
| John J Crowley | SVP, Chief Accounting Officer | 1. Oktober 2016 F | 5.599 | 0 | 0 | $0 |
| Nancy Gillett | Corporate Executive VP | 2. März 2016 S | 11.034 | 0 | 0 | $0 |
| Jorg Geller | Corporate Executive VP | 25. Februar 2015 M | 14.094 | 0 | 0 | $0 |
| RENAUD REAL H | Corp. Executive VP | 11. August 2010 F | 74.390 | 0 | 0 | $0 |
| Christopher Berthoux | Executive Vice President | 26. Februar 2010 A | 31.897 | 0 | 0 | $0 |
| Joanne P Acford | Corp. Sr VP, GC and Corp. Sec | 11. August 2007 F | 37.109 | 0 | 0 | $0 |
| David J Elliott | Officer | 29. Juni 2007 M | 11.750 | 0 | 0 | $0 |
| Cheri L Walker | Corporate Senior VP | 1. Mai 2007 A | 6.262 | 0 | 0 | $0 |
| Stephanie B Wells | Senior Vice President | 2. April 2007 A | 11.500 | 0 | 0 | $0 |
| Nicholas Ventresca | Senior Vice President | 2. April 2007 F | 12.713 | 0 | 0 | $0 |
| John C Ho | Senior Vice President | 23. Februar 2007 A | 12.710 | 0 | 0 | $0 |
| Brian Bathgate | Corporate Vice President | 27. Februar 2006 S | 16.134 | 0 | 0 | $0 |
| Alastair Stuart Mcewan | Corporate VP | 23. Dezember 2004 M | 8.000 | 0 | 0 | $0 |
| James C Foster | Direktor | 25. August 2026 M | 31.596 | 0 | 3 | $-34.844.875 |
| Nancy C Andrews | Direktor | 18. August 2026 M | 1.438 | 0 | 1 | $-163.443 |
| Steven Barg | Direktor | 2. Juni 2026 A | 3.287 | 0 | 0 | $0 |
| Reshema Kemps-Polanco | Direktor | 8. Mai 2026 A | 4.563 | 0 | 0 | $0 |
| George Llado | Direktor | 8. Mai 2026 A | 6.702 | 0 | 0 | $0 |
| Abraham Ceesay | Direktor | 8. Mai 2026 A | 2.384 | 0 | 0 | $0 |
| Mark J Enyedy | Direktor | 8. Mai 2026 A | 2.384 | 0 | 0 | $0 |
| Paul W Graves | Direktor | 8. Mai 2026 A | 2.384 | 0 | 0 | $0 |
| Craig B. Thompson | Direktor | 8. Mai 2026 A | 3.851 | 0 | 0 | $0 |
| Martin Mackay | Direktor | 8. Mai 2026 A | 17.137 | 0 | 0 | $0 |
| Virginia M Wilson | Direktor | 8. Mai 2026 A | 6.349 | 0 | 0 | $0 |
| George Massaro | Direktor | 15. Mai 2025 S | 5.575 | 0 | 0 | $0 |
| Richard F Wallman | Direktor | 7. November 2024 S | 0 | 0 | 0 | $0 |
| Deborah Turner Kochevar | Direktor | 13. Mai 2024 A | 7.894 | 0 | 0 | $0 |
| Robert J Bertolini | Direktor | 13. Mai 2024 A | 32.802 | 0 | 0 | $0 |
| Richard C Reese | Direktor | 15. Mai 2023 A | 65.541 | 0 | 0 | $0 |
| George M Milne JR | Direktor | 7. Mai 2021 A | 29.079 | 0 | 0 | $0 |
| Stephen D Chubb | Direktor | 23. Februar 2021 M | 40.529 | 0 | 0 | $0 |
| Jean-Paul Mangeolle | Direktor | 22. Mai 2019 A | 3.886 | 0 | 0 | $0 |
| William Waltrip | Direktor | 5. Dezember 2012 S | 21.830 | 0 | 0 | $0 |
| Samuel O Thier MD | Direktor | 9. Mai 2012 A | 18.230 | 0 | 0 | $0 |
| Douglas E Rogers | Direktor | 7. Mai 2010 A | 12.859 | 0 | 0 | $0 |
| Nancy T Chang | Direktor | 7. Mai 2010 A | 31.010 | 0 | 0 | $0 |
| Linda Mcgoldrick | Direktor | 13. Februar 2006 A | · | 0 | 0 | $0 |
| Walter S Nimmo | Direktor | 25. Februar 2005 S | 149.447 | 0 | 0 | $0 |
| John Urquhart | Direktor | 17. Februar 2005 A | 11.738 | 0 | 0 | $0 |
| Louise S Mccrary | Direktor | 17. Februar 2005 A | · | 0 | 0 | $0 |
| Robert Cawthorn | Direktor | 2. Juni 2004 G | 278.600 | 0 | 0 | $0 |
| Joseph W Laplume | · | 10. August 2026 G | 31.041 | 1 | 1 | $-61.124 |
| Victoria L Creamer | · | 6. August 2026 M | 30.051 | 0 | 1 | $-1.083.030 |
| Michael Gunnar Knell | · | 6. August 2026 M | 11.852 | 0 | 9 | $-1.730.250 |
| Thomas F Ackerman | · | 29. Februar 2016 F | 111.346 | 0 | 0 | $0 |
| Dennis R Shaughnessy | · | 29. November 2004 G | 35.511 | 0 | 0 | $0 |
| Michael F Ankcorn | · | 4. November 2004 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 106 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| EPSB · Harbor ETF Trust | 2,15% | 443 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,73% | 51.248 SH | 1. Oktober 2026 | Täglich |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,71% | 5.092 NS | 31. Juli 2026 | N-PORT |
| EPSV · Harbor ETF Trust | 1,59% | 415 NS | 31. Juli 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,44% | 291 NS | 31. Juli 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 1,09% | 4.303 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,96% | 363.741 SH | 11. September 2026 | Täglich |
| LSEQ · Harbor ETF Trust | 0,93% | 614 NS | 31. Juli 2026 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0,74% | 2.375 NS | 31. Juli 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0,69% | 22.191 SH | 1. Oktober 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,66% | 259 NS | 31. Juli 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,61% | 5.509 NS | 31. Juli 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,49% | 12.141 NS | 31. Juli 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,45% | 6.439 NS | 31. Juli 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,44% | 24.918 SH | 1. Oktober 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,40% | 25.814 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,34% | 209.615 NS | 31. Juli 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,28% | 7.783 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,24% | 25.082 SH | 11. September 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 20.898 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,24% | 25.378 NS | 31. Juli 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,23% | 13.626 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,23% | 701.498 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,22% | 147.648 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 702.813 SH | 1. Oktober 2026 | Täglich |
| IYH · iShares Trust | 0,22% | 28.670 SH | 11. September 2026 | Täglich |
| SMMD · iShares Trust | 0,19% | 26.152 SH | 11. September 2026 | Täglich |
| IXJ · iShares Trust | 0,17% | 25.598 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 23.486 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,16% | 148.331 SH | 19. August 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,15% | 2.111 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 3.646 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,14% | 6.080 SH | 11. September 2026 | Täglich |
| IWS · iShares Trust | 0,13% | 73.404 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,13% | 1.102.914 SH | 19. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,13% | 947 NS | 31. Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 42.976 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 2.764 SH | 1. Oktober 2026 | Täglich |
| IEUS · iShares Trust | 0,10% | 5.579 SH | 11. September 2026 | Täglich |
| IWR · iShares Trust | 0,10% | 200.615 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,10% | 23.999 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,07% | 61 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,06% | 41.352 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,06% | 1.302 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,05% | 106.991 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,04% | 79.930 SH | 11. September 2026 | Täglich |
| IUSV · iShares Trust | 0,04% | 42.675 SH | 11. September 2026 | Täglich |
| SCZ · iShares Trust | 0,04% | 171.786 SH | 11. September 2026 | Täglich |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 174.824 SH | 19. August 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 11.139 SH | 19. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,04% | 5.545 NS | 31. Juli 2026 | N-PORT |
| IWD · iShares Trust | 0,04% | 108.791 SH | 11. September 2026 | Täglich |
| CHRI · Global X Funds | 0,03% | 11 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 29.579 SH | 19. August 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 9.073 SH | 1. Oktober 2026 | Täglich |
| TOPC · iShares Trust | 0,03% | 32 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,02% | 2.431 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,02% | 576 SH | 11. September 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 1.252 SH | 1. Oktober 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 287 SH | 30. September 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 7.028 SH | 1. Oktober 2026 | Täglich |
| EGLE · Global X Funds | 0,02% | 2 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 607.129 SH | 11. September 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 1.250.774 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.530.468 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.168 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4.112 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11.106 SH | 19. August 2026 | Täglich |
| IWV · iShares Trust | 0,02% | 14.165 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,02% | 33.863 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,02% | 41 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 9.979 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 2.566 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 2.018 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,02% | 63.582 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 38 SH | 1. Oktober 2026 | Täglich |
| PTLC · Pacer Funds Trust | 0,02% | 2.492 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 1.620 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 14.645 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 45 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,02% | 182 NS | 31. Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,02% | 1.141 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 3 NS | 31. Juli 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 332 NS | 31. Juli 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,01% | 3.766 NS | 31. Juli 2026 | N-PORT |
| IEUR · iShares Trust | 0,01% | 37.473 SH | 11. September 2026 | Täglich |
| XCLR · Global X Funds | 0,01% | 2 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.973 SH | 1. Oktober 2026 | Täglich |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 110.946 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 77.796 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 447.656 SH | 19. August 2026 | Täglich |
| IDEV · iShares Trust | 0,01% | 52.174 SH | 11. September 2026 | Täglich |
| IEFA · iShares Trust | 0,00% | 272.340 SH | 11. September 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,00% | 140.000 SH | 9. September 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,00% | 377 NS | 31. Juli 2026 | N-PORT |
| IXUS · iShares Trust | 0,00% | 22.623 SH | 11. September 2026 | Täglich |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 664.961 SH | 19. August 2026 | Täglich |
| VSGX · VANGUARD WORLD FUND | 0,00% | 8.805 SH | 19. August 2026 | Täglich |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| ISCB · iShares Trust | · | 2.146 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 10.576 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 18.703 SH | 11. September 2026 | Täglich |
CRL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 23 Analysten
KAUF
Median-Ziel
$322.00
+11,0%
6 26,1%
Starker Kauf
11 47,8%
Kauf
6 26,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
15 Analysten · 2026-10-02Mittelwert-Ziel $305.00 +5,1%
Jetzt
Aktueller Preis $290.19
Tief$145.00
Mittelwert$305.00
Hoch$357.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| BIO | · | · | · | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Bio-Techne verdrängt Charles River Laboratories International von Platz 477
Nasdaq · 3 Monate vor
Charles River Laboratories International Q1 Earnings Call Highlights
Yahoo Finance · 4 Monate, 3 Wochen vor
Tokenisierte Krypto-US-Staatsanleihen nähern sich 14 Milliarden Dollar, während Circle und BlackRock das Wachstum anführen
Yahoo Finance · 5 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026